Citigroup’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $710K | Sell |
229,814
-32,022
| -12% | -$98.9K | ﹤0.01% | 2712 |
|
2025
Q1 | $914K | Buy |
261,836
+74,116
| +39% | +$259K | ﹤0.01% | 2598 |
|
2024
Q4 | $614K | Buy |
187,720
+78,669
| +72% | +$257K | ﹤0.01% | 2893 |
|
2024
Q3 | $420K | Sell |
109,051
-1,032,262
| -90% | -$3.97M | ﹤0.01% | 3096 |
|
2024
Q2 | $3.53M | Buy |
1,141,313
+914,425
| +403% | +$2.83M | ﹤0.01% | 1374 |
|
2024
Q1 | $585K | Buy |
226,888
+205,603
| +966% | +$530K | ﹤0.01% | 2753 |
|
2023
Q4 | $53.2K | Sell |
21,285
-117,571
| -85% | -$294K | ﹤0.01% | 3740 |
|
2023
Q3 | $282K | Buy |
138,856
+61,098
| +79% | +$124K | ﹤0.01% | 2781 |
|
2023
Q2 | $179K | Buy |
77,758
+75,978
| +4,268% | +$175K | ﹤0.01% | 3277 |
|
2023
Q1 | $5.39K | Sell |
1,780
-993
| -36% | -$3.01K | ﹤0.01% | 4240 |
|
2022
Q4 | $6.46K | Sell |
2,773
-654
| -19% | -$1.52K | ﹤0.01% | 4252 |
|
2022
Q3 | $7K | Sell |
3,427
-6,170
| -64% | -$12.6K | ﹤0.01% | 4338 |
|
2022
Q2 | $26K | Buy |
9,597
+2,803
| +41% | +$7.59K | ﹤0.01% | 4159 |
|
2022
Q1 | $20K | Sell |
6,794
-17,860
| -72% | -$52.6K | ﹤0.01% | 4394 |
|
2021
Q4 | $96K | Buy |
24,654
+9,975
| +68% | +$38.8K | ﹤0.01% | 3989 |
|
2021
Q3 | $63K | Buy |
14,679
+5,117
| +54% | +$22K | ﹤0.01% | 3873 |
|
2021
Q2 | $29K | Sell |
9,562
-20,828
| -69% | -$63.2K | ﹤0.01% | 4421 |
|
2021
Q1 | $101K | Sell |
30,390
-24,880
| -45% | -$82.7K | ﹤0.01% | 3700 |
|
2020
Q4 | $196K | Buy |
55,270
+46,724
| +547% | +$166K | ﹤0.01% | 3248 |
|
2020
Q3 | $27K | Buy |
8,546
+5,600
| +190% | +$17.7K | ﹤0.01% | 3774 |
|
2020
Q2 | $5K | Sell |
2,946
-100
| -3% | -$170 | ﹤0.01% | 4802 |
|
2020
Q1 | $3K | Sell |
3,046
-2,714
| -47% | -$2.67K | ﹤0.01% | 4873 |
|
2019
Q4 | $16K | Sell |
5,760
-2,168
| -27% | -$6.02K | ﹤0.01% | 4556 |
|
2019
Q3 | $12K | Sell |
7,928
-4,985
| -39% | -$7.55K | ﹤0.01% | 4482 |
|
2019
Q2 | $27K | Buy |
12,913
+3,127
| +32% | +$6.54K | ﹤0.01% | 4446 |
|
2019
Q1 | $35K | Sell |
9,786
-759
| -7% | -$2.72K | ﹤0.01% | 4238 |
|
2018
Q4 | $41K | Sell |
10,545
-13,579
| -56% | -$52.8K | ﹤0.01% | 4034 |
|
2018
Q3 | $228K | Buy |
24,124
+14,751
| +157% | +$139K | ﹤0.01% | 3074 |
|
2018
Q2 | $68K | Buy |
9,373
+5,687
| +154% | +$41.3K | ﹤0.01% | 3678 |
|
2018
Q1 | $18K | Buy |
3,686
+702
| +24% | +$3.43K | ﹤0.01% | 4257 |
|
2017
Q4 | $15K | Sell |
2,984
-10,012
| -77% | -$50.3K | ﹤0.01% | 4343 |
|
2017
Q3 | $81K | Buy |
12,996
+2,000
| +18% | +$12.5K | ﹤0.01% | 3472 |
|
2017
Q2 | $40K | Sell |
10,996
-2,364
| -18% | -$8.6K | ﹤0.01% | 3685 |
|
2017
Q1 | $44K | Sell |
13,360
-51,800
| -79% | -$171K | ﹤0.01% | 3727 |
|
2016
Q4 | $160K | Buy |
65,160
+27,700
| +74% | +$68K | ﹤0.01% | 3695 |
|
2016
Q3 | $129K | Buy |
37,460
+600
| +2% | +$2.07K | ﹤0.01% | 3264 |
|
2016
Q2 | $128K | Buy |
36,860
+3,959
| +12% | +$13.7K | ﹤0.01% | 3155 |
|
2016
Q1 | $136K | Buy |
32,901
+19,851
| +152% | +$82.1K | ﹤0.01% | 3769 |
|
2015
Q4 | $58K | Sell |
13,050
-3,982
| -23% | -$17.7K | ﹤0.01% | 3968 |
|
2015
Q3 | $103K | Sell |
17,032
-25,150
| -60% | -$152K | ﹤0.01% | 3164 |
|
2015
Q2 | $501K | Sell |
42,182
-45,770
| -52% | -$544K | ﹤0.01% | 2153 |
|
2015
Q1 | $1.54M | Sell |
87,952
-1,273
| -1% | -$22.2K | ﹤0.01% | 1480 |
|
2014
Q4 | $1.37M | Buy |
89,225
+87,743
| +5,921% | +$1.34M | ﹤0.01% | 1541 |
|
2014
Q3 | $31K | Sell |
1,482
-1,165
| -44% | -$24.4K | ﹤0.01% | 3982 |
|
2014
Q2 | $35K | Buy |
2,647
+650
| +33% | +$8.6K | ﹤0.01% | 3790 |
|
2014
Q1 | $44K | Buy |
1,997
+1,162
| +139% | +$25.6K | ﹤0.01% | 4034 |
|
2013
Q4 | $6K | Buy |
+835
| New | +$6K | ﹤0.01% | 4967 |
|
2013
Q3 | – | Sell |
-20
| Closed | – | – | 5128 |
|
2013
Q2 | $0 | Buy |
+20
| New | – | ﹤0.01% | 5076 |
|